• #36: Tackling Health Inequities in Chronic Disease using AI/ML with Kanishka Rao, COO and Co-Founder of Carenostics

  • Jun 9 2023
  • Duración: 33 m
  • Podcast

#36: Tackling Health Inequities in Chronic Disease using AI/ML with Kanishka Rao, COO and Co-Founder of Carenostics Por arte de portada

#36: Tackling Health Inequities in Chronic Disease using AI/ML with Kanishka Rao, COO and Co-Founder of Carenostics

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • What you’ll get out of this episodeListen in as host Tim Fitzpatrick chats with Kanishka Rao about the unexpected loss of his grandfather, who passed away from kidney disease, and how he was not aware he had kidney disease until his kidneys had already failed. Because of this, Kanishka and his father, Bharat, co-founded Carenostics with the goal of tackling the underdiagnosis, undertreatment, and health inequities of chronic disease. Carenostics’ vision is to transform healthcare into a data-driven paradigm where readily-available patient data is leveraged to make personalized patient recommendations for diagnostic and therapy decisions.In this episode you’ll discover:Carenostics serves both physicians and patients by streamlining the diagnosis process for patients with chronic diseases and ensuring the patient is receiving proper diagnosis and more personalized treatment.How Kanishka and Bharat think about existing barriers to Carenostics short- and long-term success, including (1) provider friction; (2) changing workflows; and (3) cost.Technical questions that arise from using AI in these diagnostic settings, including around temporal stability, which refers to the question of keeping a model you’ve trained updated as you add new patients and guidelines to the data set. Questions also arise around bias adjustment and the cost of being wrong while using tools like generative AI to take on more and more of your administrative and decision making tasks.Carenostics just received the Bio-IT World Innovative Practices Award in 2023 alongside their partners at Hackensack Meridian Health for their AI approach to identifying undiagnosed CKD and activating clinicians at the point of care. Past winners include Astrazeneca, Merck, Regeneron, and Duke University.Kanishka and his team strive to change the status quo by shifting the way practitioners diagnose and treat patients to a more data-driven model where readily-available patient data is leveraged to make personalized patient recommendations for diagnostic and therapy decisions. This could save millions of lives through early diagnosis and intervention, and appropriate long-term treatment and care.Final Frontier - 5 Questions in 50 SecondsTop Challenge: Talent / hiringTop Opportunity: Awareness / acceptance of AITech Trend You’re Following: Bias-adjusted AITop Media Recs: Shoe Dog, by Phil KnightHealthcare / Tech Leader(s) You’re Following: Aneesh ChopraQuotables“When I reflect back to that first conversation with my dad, one of the first questions I asked was ‘You built these models 2 decades ago – the first FDA-approved way of diagnosing lung cancer from CT scans, it’s one of Baret’s patents – you know why isn’t AI used every day at the point of care. AI is not a new thing.’ The biggest reason was provider friction, and all these different models of charging providers morbid amounts of money for these operating systems, diverting them to a different workflow, providing black box recommendations or, fundamentally even trying to change the way they deliver care.” @KanishkaRao #Carenostics on Ep26 @t-minus10 w/ @trfitzpatrick Recommended ResourcesCarenostics Debuts AI-Driven Tool to Diagnose Chronic Kidney Disease (Carenostics)Bio-IT World Names 2023 Innovative Practices Winners (Bio IT World)SBIR Phase I: Artificial intelligence platform for secure, collaborative learning across medical institutions (NSF Award Search)Is the Software Function Intended to Provide Clinical Decision Support? (FDA)Join the Conversation Kanishka Rao on LinkedInBharat Rao on LinkedInCarenostics on LinkedIn“Thrilled to have our partnership with Hackensack Meridian Health awarded the Bio-IT World Innovative Practices Award! Excited to have our work using AI for CKD recognized alongside other innovative recipients, including AbbVie, City of Hope, & Regeneron!Thank you to Bayer G4A for the nomination - and looking forward to presenting with Bharat Rao & Kash Patel at the conference on May 18th! “ @Kanisha Rao on LinkedIn About Your HostTim Fitzpatrick is the CEO of IKONA Health, a company using neurobiology and immersive technology to improve how patients learn about their care and treatment options. Tim co-founded IKONA based on his own patient experiences while serving in the US Navy and now in the VA health system. He has served as Principal Investigator on multiple federal research grants, has co-authored papers on learning science, VR, and mental health in the age of COVID-19, and has partnered with top healthcare investors and institutions including the National Science Foundation, Department of Defense, National Artificial Intelligence Institute, StartUp Health, On Deck, FundRx, MATTER and NVIDIA.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre #36: Tackling Health Inequities in Chronic Disease using AI/ML with Kanishka Rao, COO and Co-Founder of Carenostics

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles